3.1. BCL2 and BCR-ABL1 Kinase Dual Inhibition Exercises Anti-Clonogenic and Anti-Proliferation Activity on Committed CP-CML Progenitors. This evidence concerns the gene BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive.